Ehtisham Haider

Faisalabad, PB, Pakistan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Semaglutide-induced lean mass loss: clinical concern or physiological adaptation.

Semaglutide-induced lean mass loss: clinical concern or physiological adaptation.

Journal: Annals of medicine and surgery (2012)
Published: April 16, 2026

Brensocatib in non-cystic fibrosis bronchiectasis: targeting neutrophil-driven inflammation through DPP-1 inhibition.

Brensocatib in non-cystic fibrosis bronchiectasis: targeting neutrophil-driven inflammation through DPP-1 inhibition.

Journal: Annals of medicine and surgery (2012)
Published: April 07, 2026

Suzetrigine (Journavx): first-in-class NaV1.8 sodium-channel blocker offering non-opioid oral relief for moderate-to-severe acute pain.

Suzetrigine (Journavx): first-in-class NaV1.8 sodium-channel blocker offering non-opioid oral relief for moderate-to-severe acute pain.

Journal: Annals of medicine and surgery (2012)
Published: February 23, 2026

Commentary: Artificial intelligence and precision medicine: a pilot study predicting optimal ceftaroline dosage for pediatric patients.

Commentary: Artificial intelligence and precision medicine: a pilot study predicting optimal ceftaroline dosage for pediatric patients.

Journal: Frontiers in artificial intelligence
Published: February 10, 2026

FDA approval of SetPoint System: the first neuroimmune modulation therapy for rheumatoid arthritis.

FDA approval of SetPoint System: the first neuroimmune modulation therapy for rheumatoid arthritis.

Journal: Annals of medicine and surgery (2012)
Published: November 30, 2025

Early-career training in neurosurgery post-COVID: simulation, mentorship, and minimal case-volume concerns.

Early-career training in neurosurgery post-COVID: simulation, mentorship, and minimal case-volume concerns.

Journal: Annals of medicine and surgery (2012)
Published: November 27, 2025

Avutometinib (Avmapki): oral RAF/MEK clamp inhibitor advancing precision therapy in KRAS-mutant low-grade serous ovarian cancer.

Avutometinib (Avmapki): oral RAF/MEK clamp inhibitor advancing precision therapy in KRAS-mutant low-grade serous ovarian cancer.

Journal: Annals of medicine and surgery (2012)
Published: November 27, 2025

Critical appraisal of Artificial Intelligence and deep-learning tools for intraoperative neurosurgery: hype versus evidence.

Critical appraisal of Artificial Intelligence and deep-learning tools for intraoperative neurosurgery: hype versus evidence.

Journal: Annals of medicine and surgery (2012)
Published: November 27, 2025

Clinical significance of Zongertinib in HER2-mutated non-small cell lung cancer: advancing targeted therapy options.

Clinical significance of Zongertinib in HER2-mutated non-small cell lung cancer: advancing targeted therapy options.

Journal: Annals of medicine and surgery (2012)
Published: November 23, 2025

Correction: Key considerations of explainable machine learning models for the early forecasting of acute kidney injury following cardiac surgery.

Correction: Key considerations of explainable machine learning models for the early forecasting of acute kidney injury following cardiac surgery.

Journal: International urology and nephrology
Published: November 21, 2025

FDA expanded approval of Pluvicto (Lutetium-177 vipivotide tetraxetan) in metastatic castration-sensitive prostate cancer.

FDA expanded approval of Pluvicto (Lutetium-177 vipivotide tetraxetan) in metastatic castration-sensitive prostate cancer.

Journal: Annals of medicine and surgery (2012)
Published: November 19, 2025

Malnutrition, contaminated water, and post-infectious neuropathies: lessons from the Guillain-Barré syndrome outbreak in Gaza.

Malnutrition, contaminated water, and post-infectious neuropathies: lessons from the Guillain-Barré syndrome outbreak in Gaza.

Journal: Annals of medicine and surgery (2012)
Published: November 07, 2025
Showing 1-12 of 28

Last Updated: 09/26/2026